Insmed
INSM
Insmed (INSM) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Truist Securities | Maintained | Buy | $195.00 from $185.00 | Aug 10, 2026 |
| JP Morgan | Maintained | Overweight | $175.00 from $179.00 | Aug 10, 2026 |
| Wells Fargo | Maintained | Overweight | $169.00 from $161.00 | Aug 7, 2026 |
| Evercore ISI Group | Maintained | Outperform | $170.00 from $160.00 | Aug 7, 2026 |
| Guggenheim | Maintained | Buy | $205.00 from $207.00 | Aug 7, 2026 |
| BMO Capital | Initiated Coverage | Outperform | $192.00 | Jul 21, 2026 |
| Wells Fargo | Maintained | Overweight | $161.00 from $160.00 | Jul 15, 2026 |
| Guggenheim | Maintained | Buy | $207.00 | Jul 10, 2026 |
| Evercore ISI Group | Maintained | Outperform | $160.00 from $162.00 | Jun 22, 2026 |
| JP Morgan | Maintained | Overweight | $179.00 from $180.00 | Jun 8, 2026 |
| RBC Capital | Maintained | Outperform | $195.00 from $205.00 | Jun 5, 2026 |
| Truist Securities | Maintained | Buy | $185.00 from $205.00 | May 14, 2026 |
| Guggenheim | Maintained | Buy | $226.00 from $230.00 | May 8, 2026 |
| Wells Fargo | Maintained | Overweight | $160.00 from $177.00 | May 8, 2026 |
| RBC Capital | Maintained | Outperform | $205.00 from $220.00 | May 8, 2026 |
| Roth Capital | Maintained | Buy | $212.00 | Apr 17, 2026 |
| RBC Capital | Maintained | Outperform | $216.00 from $212.00 | Apr 14, 2026 |
| Barclays | Maintained | Overweight | $237.00 from $231.00 | Apr 1, 2026 |
| Morgan Stanley | Upgraded | Equal-Weight → Overweight | $212.00 from $166.00 | Mar 30, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $245.00 from $230.00 | Mar 26, 2026 |
Frequently asked questions
What is the latest analyst rating on INSM?
On Aug 10, 2026, Truist Securities maintained Insmed at Buy with a price target of $195.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.